(1) Hemoglobin electrophoresis:HbH, Bart’s and Hb variant not detected
(2) HbA2(資料來源:Wong ECC, et al. 2009 meeting of ISLH)
(A)0-6 days:0.0-0.0%
(B) 7-14 days:0.0-0.4%
(C) 15-45 days:0.0-1.8%
(D)45days-3months:0.3-2.4%
(E) 3-6 months:1.7-2.7%
(F) 6-9 months:2.0-3.0%
(G)9-15 months:2.2-3.2%
(H)15 months-2 years:2.4-3.1%
(I) 2-6 years:2.2-3.2%
(J) 6-17 years:1.9-3.3%
(K)≧18 years:2.4-2.9%
(L) beta thalassemia:HbA2>3.0%(相當HPLC>3.5%)
(3) Hb F(資料來源:Wong ECC, et al. 2009 meeting of ISLH)
(A)0-6 days:79.4-97.9%
(B) 7-14 days:66.0-98.4%
(C) 15-45 days:49.9-98.4%
(D)45days-3months:10.3-64.6%
(E) 3-6 months:5.2-34.5%
(F) 6-9 months:1.1-28.5%
(G)9-15 months:0.2-9.9%
(H)15 months-2 years:0.0-5.5%
(I) 2-6 years:0.0-1.6%
(J) 6-17 years:0.0-0.0%
(K)≧18 years:0.0-0.0%
(4) Hb H(BCB test):0%
|